Results
1
Companies which are more than 50% undervalued based on analyst price target.
1 companies
Marinomed Biotech
Market Cap: €36.7m
A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.
MARI
€19.95
7D
0.8%
1Y
110.0%